EU GMP Annex 11 & 21 CFR Part 11 – Computerised Systems & E-Records

Configurable vs Custom Applications: Annex 11 and Part 11 Impact on CSV In the realm of pharmaceutical validation, understanding the nuances between configurable and custom applications is critical for ensuring compliance with regulatory standards. This article explores the implications of these categories within the framework of Annex 11 and 21 CFR Part 11, focusing on their impact on computer system…

Risk-Based Testing of GxP Systems: Applying Annex 11 and GAMP 5 Principles In an era where global pharmaceutical regulations are continuously evolving, risk-based validation approaches have taken a front seat, especially with the advent of Annex 11 and GAMP 5 principles governing computerized systems. This regulatory explainer manual focuses on the nuanced expectations surrounding risk-based CSV testing under the auspices…

Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems The integration of electronic systems in the pharmaceutical industry necessitates rigorous adherence to regulatory expectations, particularly in relation to electronic archiving and data retention. With both the US FDA’s Part 11 regulations and the EMA’s Annex 11, understanding the specific requirements becomes paramount to ensure compliance and maintain…

Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching Introduction to Inspection Readiness for Annex 11 and Part 11 In the pharmaceutical industry, compliance with regulatory standards is paramount for ensuring the quality, safety, and efficacy of products. Among these regulations, EU GMP Annex 11 and the US FDA…

Hybrid Systems: Controlling Paper–Electronic Interfaces Under Annex 11 and Part 11 In today’s pharmaceutical landscape, integrating traditional paper-based processes with electronic systems has become a necessity. Hybrid systems—the combination of paper and electronic records—are prevalent in many organizations as they strive for compliance with regulatory guidelines such as the US FDA‘s requirements and the European Medicines Agency’s (EMA) Annex 11….

Managing Electronic Batch Records in Annex 11/Part 11–Regulated Environments Managing Electronic Batch Records in Annex 11/Part 11–Regulated Environments The pharmaceutical industry is undergoing a significant transformation with the increasing reliance on electronic batch records (EBR) to streamline operations and enhance compliance with regulatory requirements. The validation and management of EBR in accordance with 21 CFR Part 11 and EU GMP…

21 CFR Part 11 and Annex 11 for LIMS, QMS, and MES Platforms Introduction to Regulatory Validation Expectations In the highly regulated pharmaceutical industry, compliance with validation requirements for computerized systems, particularly for Laboratory Information Management Systems (LIMS), Quality Management Systems (QMS), and Manufacturing Execution Systems (MES), is crucial. This article provides an in-depth regulatory explainer manual addressing the expectations…

Change Control for Annex 11/Part 11 Systems: Impact Assessment and Regression Testing Change control is a core component of pharmaceutical validation, particularly when it concerns computerized systems governed by Annex 11 of the EU GMP Guidelines and 21 CFR Part 11 from the FDA. This regulatory explainer manual provides a comprehensive overview of change control requirements for these systems, emphasizing…

Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching Preparing for Annex 11/Part 11–Focused Inspections: Storyboards and SME Coaching In the pharmaceutical industry, regulations surrounding computerized systems and electronic records are increasingly stringent. Both Annex 11 of the EU Good Manufacturing Practice (GMP) guidelines and 21 CFR Part 11 of the US FDA regulation emphasize the importance of compliance…

Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems Electronic Archiving and Data Retention for Annex 11 and Part 11 Systems The digital transformation of the pharmaceutical industry necessitates a robust framework for electronic archiving and data retention. Compliance with FDA, EMA, and other regulatory authorities regarding electronic records demands a thorough understanding of the embedded requirements…